Karl E. Herbert

3.6k total citations
65 papers, 2.1k citations indexed

About

Karl E. Herbert is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Karl E. Herbert has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Rheumatology. Recurrent topics in Karl E. Herbert's work include DNA Repair Mechanisms (10 papers), Carcinogens and Genotoxicity Assessment (10 papers) and DNA and Nucleic Acid Chemistry (8 papers). Karl E. Herbert is often cited by papers focused on DNA Repair Mechanisms (10 papers), Carcinogens and Genotoxicity Assessment (10 papers) and DNA and Nucleic Acid Chemistry (8 papers). Karl E. Herbert collaborates with scholars based in United Kingdom, United States and Netherlands. Karl E. Herbert's co-authors include Marcus S. Cooke, Helen R. Griffiths, Mark D. Evans, Pratibha Mistry, John Lunec, Nalini Mistry, Bryan Williams, Ian D. Podmore, David I. Perrett and J. Lunec and has published in prestigious journals such as Nature, Circulation Research and The Lancet Oncology.

In The Last Decade

Karl E. Herbert

65 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl E. Herbert United Kingdom 25 905 388 352 290 221 65 2.1k
Cécile Mazière France 31 1.2k 1.3× 258 0.7× 310 0.9× 441 1.5× 158 0.7× 119 2.9k
Jean‐François Savouret France 27 779 0.9× 208 0.5× 273 0.8× 250 0.9× 119 0.5× 41 2.1k
Silvia Borrello Italy 27 1.5k 1.6× 350 0.9× 361 1.0× 416 1.4× 33 0.1× 46 2.5k
Bo Yuan Japan 28 1.1k 1.3× 209 0.5× 140 0.4× 247 0.9× 79 0.4× 109 2.2k
Simona Zarini United States 30 970 1.1× 122 0.3× 656 1.9× 423 1.5× 52 0.2× 58 2.6k
Francisco J. Sánchez-Gómez Spain 21 714 0.8× 145 0.4× 285 0.8× 163 0.6× 146 0.7× 34 1.4k
Konjeti R. Sekhar United States 31 2.2k 2.5× 274 0.7× 305 0.9× 170 0.6× 77 0.3× 65 3.3k
Tomonaga Ichikawa Japan 22 1.3k 1.4× 284 0.7× 339 1.0× 375 1.3× 60 0.3× 47 2.3k
Flavio Flamigni Italy 30 1.6k 1.8× 325 0.8× 225 0.6× 160 0.6× 485 2.2× 112 2.5k
Renata Colavitti Italy 17 1.3k 1.5× 324 0.8× 418 1.2× 431 1.5× 26 0.1× 21 2.3k

Countries citing papers authored by Karl E. Herbert

Since Specialization
Citations

This map shows the geographic impact of Karl E. Herbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl E. Herbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl E. Herbert more than expected).

Fields of papers citing papers by Karl E. Herbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl E. Herbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl E. Herbert. The network helps show where Karl E. Herbert may publish in the future.

Co-authorship network of co-authors of Karl E. Herbert

This figure shows the co-authorship network connecting the top 25 collaborators of Karl E. Herbert. A scholar is included among the top collaborators of Karl E. Herbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl E. Herbert. Karl E. Herbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pointon, Amy, et al.. (2018). Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity. Drug Metabolism and Disposition. 46(8). 1053–1065. 53 indexed citations
2.
Burton, James O., Karl E. Herbert, Jeremy R. Glissen Brown, et al.. (2015). Hyperphosphatemia, Phosphoprotein Phosphatases, and Microparticle Release in Vascular Endothelial Cells. Journal of the American Society of Nephrology. 26(9). 2152–2162. 50 indexed citations
3.
Mistry, Pratibha, et al.. (2014). Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity. Redox Biology. 2. 224–233. 90 indexed citations
4.
Herbert, Karl E., et al.. (2012). Oxidative and non-oxidative DNA damage and cardiovascular disease. Free Radical Research. 46(4). 554–564. 21 indexed citations
5.
Ball, Graham, Edward Choke, Karen Molyneux, et al.. (2012). Disease Specific Biomarkers of Abdominal Aortic Aneurysms Detected by Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry. European Journal of Vascular and Endovascular Surgery. 44(1). 52–54. 9 indexed citations
6.
Wilson, William R., Karl E. Herbert, Yogesh Mistry, et al.. (2008). Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. European Heart Journal. 29(21). 2689–2694. 141 indexed citations
7.
Hastings, Richard P., Peter Lacy, Hasmukh V. Patel, et al.. (2004). Rapid telomere attrition in cardiac tissue of the ageing Wistar rat. Experimental Gerontology. 39(5). 855–857. 25 indexed citations
8.
Mistry, Nalini, Ian D. Podmore, Marcus S. Cooke, et al.. (2003). Novel Monoclonal Antibody Recognition of Oxidative DNA Damage Adduct, Deoxycytidine-Glyoxal. Laboratory Investigation. 83(2). 241–250. 24 indexed citations
9.
Cooke, Marcus S., Ian D. Podmore, Nalini Mistry, et al.. (2003). Immunochemical detection of UV-induced DNA damage and repair. Journal of Immunological Methods. 280(1-2). 125–133. 31 indexed citations
10.
Cooke, Marcus S., Nalini Mistry, Helen L. Waller, et al.. (2003). Deoxycytidine glyoxal: lesion induction and evidence of repair following vitamin C supplementation in vivo. Free Radical Biology and Medicine. 34(2). 218–225. 17 indexed citations
11.
Cooke, Marcus S., et al.. (2000). Urinary 8-oxo-2′-deoxyguanosine — Source, significance and supplements. Free Radical Research. 32(5). 381–397. 186 indexed citations
12.
Griffiths, Helen R., Pratibha Mistry, Karl E. Herbert, & J. Lunec. (1998). Molecular and Cellular Effects of Ultraviolet Light-Induced Genotoxicity. Critical Reviews in Clinical Laboratory Sciences. 35(3). 189–237. 161 indexed citations
13.
Farmer, P. B., et al.. (1997). 32P-Postlabelling approaches for the detection of 8-oxo-2′-deoxyguanosine-3′-monophosphate in DNA. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 378(1-2). 139–149. 13 indexed citations
14.
Evans, Mark D., David I. Perrett, John Lunec, & Karl E. Herbert. (1997). Analysis of Urinary Pseudouridine by Micellar Electrokinetic Capillary Chromatography. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(5). 527–533. 4 indexed citations
15.
Cooke, Marcus S., et al.. (1997). Immunogenicity of DNA Damaged by Reactive Oxygen Species—Implications for Anti-DNA Antibodies in Lupus. Free Radical Biology and Medicine. 22(1-2). 151–159. 93 indexed citations
16.
Herbert, Karl E., et al.. (1994). 8‐Hydroxydeoxyguanosine. FEBS Letters. 348(2). 131–138. 117 indexed citations
17.
Herbert, Karl E., Nalini Mistry, Helen R. Griffiths, & John Lunec. (1994). Immunochemical detection of sequence-specific modifications to DNA induced by UV light. Carcinogenesis. 15(11). 2517–2521. 13 indexed citations
18.
Lunec, John, et al.. (1994). Binding of anti-DNA antibodies to oxidatively damaged DNA in spouses and relatives of patients with systemic lupus erythematosus. Immunology Letters. 41(2-3). 135–138. 4 indexed citations
20.
Perrett, David I., Karl E. Herbert, George L. Morris, & H. Anne Simmonds. (1989). Optimised Conditions for the Routine HPLC Separation of Nucleotides in Cell Extracts. Advances in experimental medicine and biology. 253B. 463–468. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026